NCT04875520

Brief Summary

The primary goal of this study is to determine the most effective SARS-CoV-2 testing strategy for successful return of in-person school in the under-served communities of St. Louis. Regular screening testing has been recommended by the CDC as an additive mitigation strategy for in-person schools in areas of high community transmission. We will compare the effectiveness and acceptance of two different school-based testing strategies among students and school staff (symptomatic testing only versus weekly surveillance testing plus symptomatic testing), measuring school-based SARS-CoV-2 transmission through a cluster randomized trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,390

participants targeted

Target at P75+ for not_applicable covid19

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable covid19

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 6, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

May 7, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

July 4, 2025

Completed
Last Updated

February 18, 2026

Status Verified

January 1, 2026

Enrollment Period

2.1 years

First QC Date

April 29, 2021

Results QC Date

December 26, 2024

Last Update Submit

January 29, 2026

Conditions

Keywords

SARS-CoV-2Screening testingSchool-based COVID-19 Transmission

Outcome Measures

Primary Outcomes (1)

  • Overall Rate of All COVID-19 Cases in Schools.

    The rate of all new COVID-19 cases of student/staff in schools per randomization group.

    Up to one year.

Study Arms (2)

Weekly Screening testing plus symptomatic testing

ACTIVE COMPARATOR

Among 16 middle and high schools, 8 will be randomized to offer students and staff weekly SARS-CoV-2 testing. Additionally, these schools will offer testing for symptomatic students, staff, household members in all age groups.

Other: Screening testing strategy

Symptomatic testing

ACTIVE COMPARATOR

All 16 schools will have testing available for individuals that have symptoms or need a test for other reasons.

Other: No screening testing strategy

Interventions

The intervention we are evaluating is the use of weekly screening testing among students and staff.

Weekly Screening testing plus symptomatic testing

a group of schools will not receive screening testing.

Symptomatic testing

Eligibility Criteria

Age0 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • A student or staff in one of the five school districts.
  • Household members of a student or staff member in the five school districts.

You may not qualify if:

  • People not affiliated with the school.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Ferguson-Florissant School District

Hazelwood, Missouri, 63042, United States

Location

Jennings School District

Jennings, Missouri, 63136, United States

Location

Pattonville School District

Saint Ann, Missouri, 63074, United States

Location

Normandy Schools Collaborative

St Louis, Missouri, 63121, United States

Location

The School District of University City

University City, Missouri, 63130, United States

Location

Related Publications (10)

  • Van Dyke ME, Mendoza MCB, Li W, Parker EM, Belay B, Davis EM, Quint JJ, Penman-Aguilar A, Clarke KEN. Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years - 16 U.S. Jurisdictions, January 1-December 31, 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):382-388. doi: 10.15585/mmwr.mm7011e1.

    PMID: 33735165BACKGROUND
  • Bryant DJ, Oo M, Damian AJ. The rise of adverse childhood experiences during the COVID-19 pandemic. Psychol Trauma. 2020 Aug;12(S1):S193-S194. doi: 10.1037/tra0000711. Epub 2020 Jun 18.

    PMID: 32551773BACKGROUND
  • Benner AD, Mistry RS. Child Development During the COVID-19 Pandemic Through a Life Course Theory Lens. Child Dev Perspect. 2020 Dec;14(4):236-243. doi: 10.1111/cdep.12387. Epub 2020 Oct 15.

    PMID: 33230400BACKGROUND
  • Zimmerman KO, Akinboyo IC, Brookhart MA, Boutzoukas AE, McGann KA, Smith MJ, Maradiaga Panayotti G, Armstrong SC, Bristow H, Parker D, Zadrozny S, Weber DJ, Benjamin DK Jr; ABC SCIENCE COLLABORATIVE. Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools. Pediatrics. 2021 Apr;147(4):e2020048090. doi: 10.1542/peds.2020-048090. Epub 2021 Jan 8.

    PMID: 33419869BACKGROUND
  • Falk A, Benda A, Falk P, Steffen S, Wallace Z, Hoeg TB. COVID-19 Cases and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August 31-November 29, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):136-140. doi: 10.15585/mmwr.mm7004e3.

    PMID: 33507890BACKGROUND
  • Orscheln RC, Newland JG, Rosen DA. Practical School Algorithms for Symptomatic or SARS-CoV-2-Exposed Students Are Essential for Returning Children to In-Person Learning. J Pediatr. 2021 Feb;229:275-277. doi: 10.1016/j.jpeds.2020.09.060. Epub 2020 Sep 25. No abstract available.

    PMID: 32980377BACKGROUND
  • To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, Lau DP, Choi CY, Chen LL, Chan WM, Chan KH, Ip JD, Ng AC, Poon RW, Luo CT, Cheng VC, Chan JF, Hung IF, Chen Z, Chen H, Yuen KY. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.

    PMID: 32213337BACKGROUND
  • Lalli MA, Langmade SJ, Chen X, Fronick CC, Sawyer CS, Burcea LC, Wilkinson MN, Fulton RS, Heinz M, Buchser WJ, Head RD, Mitra RD, Milbrandt J. Rapid and extraction-free detection of SARS-CoV-2 from saliva with colorimetric LAMP. medRxiv [Preprint]. 2020 Aug 6:2020.05.07.20093542. doi: 10.1101/2020.05.07.20093542.

    PMID: 32511508BACKGROUND
  • Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005 Nov;15(9):1277-88. doi: 10.1177/1049732305276687.

    PMID: 16204405BACKGROUND
  • Hayes S, Malone S, Bonty B, Mueller N, Reyes SM, Reyes SA, Evans C, Wilcher-Roberts M, Watterson T, Akuse S, Shelley J, Yuan G, Lackey I, Prater J, Montgomery B, Williams C, Butler-Barnes ST, Harris K, Caburnay C, Dougherty NL, Liu J, Lai A, Neidich J, Fritz S, Newland JG. Assessing COVID-19 testing strategies in K-12 schools in underserved populations: study protocol for a cluster-randomized trial. BMC Public Health. 2022 Jun 13;22(1):1177. doi: 10.1186/s12889-022-13577-z.

Related Links

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Limitations and Caveats

Small sample size. Local and federal COVID-19 recommendations and precautions were continuously changing. The omicron surge in St. Louis presented an unforeseeable strain on the study's testing resources, and symptomatic testing had to be paused for 37 days. Due to the specific PCR test utilized not being designed for a high positivity rate. Study experienced lower recruitment than expected.

Results Point of Contact

Title
Jason G. Newland, MD
Organization
Nationwide Children's Hospital

Study Officials

  • Jason G. Newland, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2021

First Posted

May 6, 2021

Study Start

May 7, 2021

Primary Completion

May 31, 2023

Study Completion

December 31, 2023

Last Updated

February 18, 2026

Results First Posted

July 4, 2025

Record last verified: 2026-01

Locations